Effect of goniothalamin on the development of Ehrlich solid tumor in mice

dc.creatorVendramini-Costa, DB
dc.creatorde Castro, IBD
dc.creatorRuiz, ALTG
dc.creatorMarquissolo, C
dc.creatorPilli, RA
dc.creatorde Carvalho, JE
dc.date2010
dc.dateSEP 15
dc.date2014-11-18T20:11:48Z
dc.date2015-11-26T17:53:42Z
dc.date2014-11-18T20:11:48Z
dc.date2015-11-26T17:53:42Z
dc.date.accessioned2018-03-29T00:37:17Z
dc.date.available2018-03-29T00:37:17Z
dc.identifierBioorganic & Medicinal Chemistry. Pergamon-elsevier Science Ltd, v. 18, n. 18, n. 6742, n. 6747, 2010.
dc.identifier0968-0896
dc.identifierWOS:000281524700016
dc.identifier10.1016/j.bmc.2010.07.053
dc.identifierhttp://www.repositorio.unicamp.br/jspui/handle/REPOSIP/63924
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/63924
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/63924
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1290596
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionIn this work the antiproliferative activity of goniothalamin (1), both in racemic and in its enantiomeric pure forms, in a solid tumor experimental model using laboratory animals is described. The antiedematogenic activity displayed by racemic 1 in the carrageenan edema model in mice together with the reduction of Ehrlich solid tumor model suggest a relationship between anticancer and antiinflammatory activities with the antiinflammatory activity favoring the antiproliferative activity itself. (c) 2010 Elsevier Ltd. All rights reserved.
dc.description18
dc.description18
dc.description6742
dc.description6747
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionNational Cancer Institute-Frederick, MA, USA
dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.descriptionCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.descriptionFAPESP [07/58665-7, 09/51602-5]
dc.languageen
dc.publisherPergamon-elsevier Science Ltd
dc.publisherOxford
dc.publisherInglaterra
dc.relationBioorganic & Medicinal Chemistry
dc.relationBioorg. Med. Chem.
dc.rightsfechado
dc.rightshttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dc.sourceWeb of Science
dc.subjectGoniothalamin
dc.subjectCancer
dc.subjectMice
dc.subjectEhrlich solid tumor
dc.subjectAnticancer Drug Screen
dc.subjectCancer-cell-lines
dc.subjectJurkat T-cells
dc.subjectNitric-oxide
dc.subjectCytotoxic Activity
dc.subjectApoptosis
dc.subjectPathways
dc.subjectInflammation
dc.subjectCarrageenan
dc.subjectPanel
dc.titleEffect of goniothalamin on the development of Ehrlich solid tumor in mice
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución